Visit my other blog »

Saturday, October 4, 2008

C'Elle Saves Lives

With the advent of new technology, more research, findings and discoveries had been done to treat various illnesses in the field of medicine. One result of study showed that stem cells found in menstrual blood proliferate rapidly and have significant potential to develop into multiple cell types. Menstrual stem cells offer an easily accessible, non-controversial and renewable stem cell source, and these findings could mean these cells have the potential to one day treat a host of diseases. This is good news to all people out there who are suffering from various illnesses.

C'Elle stem cells by Cryo-Cell International exclusive and revolutionary stem cell technology empowers women to safely and easily collect non-controversial, potentially life-saving stem cells found in menstrual blood. C'elle menstrual stem cells have demonstrated the ability to differentiate into other cell types such as heart muscle, cartilage, nerve and bone stem cells. This translates into the potential for future therapeutic developments to possibly treat major diseases like diabetes, heart disease, stroke, MS, Parkinson's and Alzheimer's; as well as possible cosmeceutical applications like anti-aging and wound-healing. Women should take control of their future healthcare by cryo-preserving their own stem cells for potential future therapeutic applications that may possibly treat a broad range of debilitating diseases. Invest in yourselves by cryopreserving your menstrual stem cells today while your body is young, healthy and disease-free. Through limited-time special promotion women can store their own stem cells for only $399 for collection, processing, testing and first year of annual storage. To order service simply go to www.Celle.com and use promotional code S399.the life you save may be your own! Right now you can receive a free gift just for talking to a representative. Visit their site to read C'Elle Testimonials.

Post?slot_id=21904&url=http%3a%2f%2fsocialspark

0 comments: